Multicenter evaluation of a high-throughput microarray platform for extensive red blood cell phenotyping and antibody screening.

Background: Blood typing and antibody screening are key elements of transfusion safety. However, available single platform, flexible, and affordable technologies are limited, especially for extended phenotyping. Microarray-based technology allows for this extended phenotyping with the flexibility of piecemeal analysis.